The HCPCS codes for Drugs, Administered by Injection are a comprehensive list of codes that describe various drugs and medications that are administered through injection. Each code represents a specific drug or medication that is administered by injection.
1. HCPCS Code J0120
HCPCS J0120 describes the injection of tetracycline, up to 250 mg, which is an antibiotic medication used to treat various bacterial infections.
2. HCPCS Code J0121
HCPCS J0121 describes the injection of omadacycline, 1 mg, which is an antibiotic medication used to treat certain types of infections.
3. HCPCS Code J0122
HCPCS J0122 describes the injection of eravacycline, 1 mg, which is an antibiotic medication used to treat complicated intra-abdominal infections.
4. HCPCS Code J0129
HCPCS J0129 describes the injection of abatacept, 10 mg, which is a medication used to treat rheumatoid arthritis and other autoimmune disorders.
5. HCPCS Code J0130
HCPCS J0130 describes the injection of abciximab, 10 mg, which is a medication used during certain heart procedures to prevent blood clotting.
6. HCPCS Code J0131
HCPCS J0131 describes the injection of acetaminophen, not otherwise specified, 10 mg, which is a pain reliever and fever reducer.
7. HCPCS Code J0132
HCPCS J0132 describes the injection of acetylcysteine, 100 mg, which is a medication used to treat acetaminophen overdose and certain respiratory conditions.
8. HCPCS Code J0133
HCPCS J0133 describes the injection of acyclovir, 5 mg, which is an antiviral medication used to treat herpes infections.
9. HCPCS Code J0134
HCPCS J0134 describes the injection of acetaminophen (fresenius kabi), not therapeutically equivalent to J0131, 10 mg, which is a pain reliever and fever reducer.
10. HCPCS Code J0135
HCPCS J0135 describes the injection of adalimumab, 20 mg, which is a medication used to treat various autoimmune disorders.
11. HCPCS Code J0136
HCPCS J0136 describes the injection of acetaminophen (b braun), not therapeutically equivalent to J0131, 10 mg, which is a pain reliever and fever reducer.
12. HCPCS Code J0137
HCPCS J0137 describes the injection of acetaminophen (hikma), not therapeutically equivalent to J0131, 10 mg, which is a pain reliever and fever reducer.
13. HCPCS Code J0153
HCPCS J0153 describes the injection of adenosine, 1 mg, which is a medication used to treat certain heart rhythm disorders.
14. HCPCS Code J0171
HCPCS J0171 describes the injection of Adrenalin (epinephrine), 0.1 mg, which is a medication used to treat severe allergic reactions and cardiac arrest.
15. HCPCS Code J0172
HCPCS J0172 describes the injection of aducanumab-avwa, 2 mg, which is a medication used to treat Alzheimer’s disease.
16. HCPCS Code J0173
HCPCS J0173 describes the injection of epinephrine (belcher), not therapeutically equivalent to J0171, 0.1 mg, which is a medication used to treat severe allergic reactions and cardiac arrest.
17. HCPCS Code J0174
HCPCS J0174 describes the injection of lecanemab-irmb, 1 mg, which is a medication used to treat Alzheimer’s disease.
18. HCPCS Code J0178
HCPCS J0178 describes the injection of aflibercept, 1 mg, which is a medication used to treat certain eye conditions.
19. HCPCS Code J0179
HCPCS J0179 describes the injection of brolucizumab-dbll, 1 mg, which is a medication used to treat certain eye conditions.
20. HCPCS Code J0180
HCPCS J0180 describes the injection of agalsidase beta, 1 mg, which is a medication used to treat Fabry disease.
21. HCPCS Code J0586
HCPCS J0586 describes the injection of abobotulinumtoxinA, 5 Units, which is a medication used for the treatment of certain muscle disorders and cosmetic purposes.
22. HCPCS Code J0587
HCPCS J0587 describes the injection of rimabotulinumtoxinB, 100 units, which is a medication used for the treatment of certain muscle disorders and cosmetic purposes.
23. HCPCS Code J0588
HCPCS J0588 describes the injection of incobotulinumtoxinA, 1 unit, which is a medication used for the treatment of certain muscle disorders and cosmetic purposes.
24. HCPCS Code J0591
HCPCS J0591 describes the injection of deoxycholic acid, 1 mg, which is a medication used for the treatment of submental fullness (double chin).
25. HCPCS Code J0592
HCPCS J0592 describes the injection of buprenorphine hydrochloride, 0.1 mg, which is a medication used for the treatment of opioid dependence and pain management.
26. HCPCS Code J0593
HCPCS J0593 describes the injection of lanadelumab-flyo, 1 mg, which is a medication used for the prevention of hereditary angioedema attacks.
27. HCPCS Code J0594
HCPCS J0594 describes the injection of Busulfan, 1 mg, which is a medication used for the treatment of certain types of cancer.
28. HCPCS Code J0595
HCPCS J0595 describes the injection of butorphanol tartrate, 1 mg, which is a medication used for the treatment of moderate to severe pain.
29. HCPCS Code J0596
HCPCS J0596 describes the injection of C1 esterase inhibitor (recombinant), ruconest, 10 units, which is a medication used for the treatment of hereditary angioedema attacks.
30. HCPCS Code J0597
HCPCS J0597 describes the injection of C-1 esterase inhibitor (human), Berinert, 10 units, which is a medication used for the treatment of hereditary angioedema attacks.
31. HCPCS Code J0598
HCPCS J0598 describes the injection of C-1 esterase inhibitor (human), Cinryze, 10 units, which is a medication used for the treatment of hereditary angioedema attacks.
32. HCPCS Code J0599
HCPCS J0599 describes the injection of C-1 esterase inhibitor (human), (haegarda), 10 units, which is a medication used for the treatment of hereditary angioedema attacks.
33. HCPCS Code J0600
HCPCS J0600 describes the injection of edetate calcium disodium, up to 1000 mg, which is a medication used for the treatment of lead poisoning and certain other conditions.
34. HCPCS Code J0604
HCPCS J0604 describes the injection of Cinacalcet, oral, 1 mg, which is a medication used for the treatment of hyperparathyroidism in patients with chronic kidney disease on dialysis.
35. HCPCS Code J0606
HCPCS J0606 describes the injection of etelcalcetide, 0.1 mg, which is a medication used for the treatment of hyperparathyroidism in patients with chronic kidney disease on dialysis.
36. HCPCS Code J0612
HCPCS J0612 describes the injection of calcium gluconate (fresenius kabi), per 10 mg, which is a medication used for the treatment of calcium deficiency and certain other conditions.
37. HCPCS Code J0613
HCPCS J0613 describes the injection of calcium gluconate (wg critical care), per 10 mg, which is a medication used for the treatment of calcium deficiency and certain other conditions.
38. HCPCS Code J0620
HCPCS J0620 describes the injection of calcium glycerophosphate and calcium lactate, per 10 ml, which is a medication used for the treatment of calcium deficiency and certain other conditions.
39. HCPCS Code J0630
HCPCS J0630 describes the injection of calcitonin salmon, up to 400 units, which is a medication used for the treatment of osteoporosis and certain other conditions.
40. HCPCS Code J0636
HCPCS J0636 describes the injection of calcitriol, 0.1 mcg, which is a medication used for the treatment of calcium deficiency and certain other conditions.
41. HCPCS Code J0637
HCPCS J0637 describes the injection of caspofungin acetate, 5 mg, which is a medication used for the treatment of fungal infections.
42. HCPCS Code J0638
HCPCS J0638 describes the injection of canakinumab, 1 mg, which is a medication used for the treatment of certain inflammatory conditions.
43. HCPCS Code J0640
HCPCS J0640 describes the injection of leucovorin calcium, per 50 mg, which is a medication used to prevent or treat certain side effects of chemotherapy.
44. HCPCS Code J0641
HCPCS J0641 describes the injection of levoleucovorin, not otherwise specified, 0.5 mg, which is a medication used to prevent or treat certain side effects of chemotherapy.
45. HCPCS Code J0642
HCPCS J0642 describes the injection of levoleucovorin (khapzory), 0.5 mg, which is a medication used to prevent or treat certain side effects of chemotherapy.
46. HCPCS Code J0665
HCPCS J0665 describes the injection of bupivacaine, not otherwise specified, 0.5 mg, which is a local anesthetic medication used for pain relief during certain medical procedures.
47. HCPCS Code J0670
HCPCS J0670 describes the injection of mepivacaine hydrochloride, per 10 ml, which is a local anesthetic medication used for pain relief during certain medical procedures.
48. HCPCS Code J0688
HCPCS J0688 describes the injection of cefazolin sodium (hikma), not therapeutically equivalent to J0690, 500 mg, which is an antibiotic medication used to treat various bacterial infections.
49. HCPCS Code J0689
HCPCS J0689 describes the injection of cefazolin sodium (baxter), not therapeutically equivalent to J0690, 500 mg, which is an antibiotic medication used to treat various bacterial infections.
50. HCPCS Code J0690
HCPCS J0690 describes the injection of cefazolin sodium, 500 mg, which is an antibiotic medication used to treat various bacterial infections.
51. HCPCS Code J0691
HCPCS J0691 describes the injection of lefamulin, 1 mg, which is an antibiotic medication used to treat certain bacterial infections.
52. HCPCS Code J0692
HCPCS J0692 describes the injection of cefepime hydrochloride, 500 mg, which is an antibiotic medication used to treat various bacterial infections.
53. HCPCS Code J0694
HCPCS J0694 describes the injection of cefoxitin sodium, 1 gm, which is an antibiotic medication used to treat various bacterial infections.
54. HCPCS Code J0695
HCPCS J0695 describes the injection of ceftolozane 50 mg and tazobactam 25 mg, which is an antibiotic medication used to treat certain bacterial infections.
55. HCPCS Code J0696
HCPCS J0696 describes the injection of ceftriaxone sodium, per 250 mg, which is an antibiotic medication used to treat various bacterial infections.
56. HCPCS Code J0697
HCPCS J0697 describes the injection of sterile cefuroxime sodium, per 750 mg, which is an antibiotic medication used to treat various bacterial infections.
57. HCPCS Code J0698
HCPCS J0698 describes the injection of cefotaxime sodium, per gm, which is an antibiotic medication used to treat various bacterial infections.
58. HCPCS Code J0699
HCPCS J0699 describes the injection of cefiderocol, 10 mg, which is an antibiotic medication used to treat certain bacterial infections.
59. HCPCS Code J0701
HCPCS J0701 describes the injection of cefepime hydrochloride (baxter), not therapeutically equivalent to Maxipime, 500 mg, which is an antibiotic medication used to treat various bacterial infections.
60. HCPCS Code J0702
HCPCS J0702 describes the injection of betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg, which is a corticosteroid medication used to treat inflammation and certain other conditions.
61. HCPCS Code J0703
HCPCS J0703 describes the injection of cefepime hydrochloride (b braun), not therapeutically equivalent to Maxipime, 500 mg, which is an antibiotic medication used to treat various bacterial infections.
62. HCPCS Code J0706
HCPCS J0706 describes the injection of Caffeine Citrate, 5 mg, which is a medication used for the treatment of apnea of prematurity in premature infants.
63. HCPCS Code J0710
HCPCS J0710 describes the injection of cephapirin sodium, up to 1 gm, which is an antibiotic medication used to treat various bacterial infections.
64. HCPCS Code J0712
HCPCS J0712 describes the injection of ceftaroline fosamil, 10 mg, which is an antibiotic medication used to treat certain bacterial infections.
65. HCPCS Code J0713
HCPCS J0713 describes the injection of ceftazidime, per 500 mg, which is an antibiotic medication used to treat various bacterial infections.
66. HCPCS Code J0714
HCPCS J0714 describes the injection of ceftazidime and avibactam, 0.5 g/0.125 g, which is an antibiotic medication used to treat certain bacterial infections.
67. HCPCS Code J0715
HCPCS J0715 describes the injection of ceftizoxime sodium, per 500 mg, which is an antibiotic medication used to treat various bacterial infections.
68. HCPCS Code J0716
HCPCS J0716 describes the injection of centruroides immune f(ab)2, up to 120 milligrams, which is a medication used for the treatment of scorpion envenomation.
69. HCPCS Code J0717
HCPCS J0717 describes the injection of certolizumab pegol, 1 mg, which is a medication used to treat various autoimmune disorders.
70. HCPCS Code J0720
HCPCS J0720 describes the injection of chloramphenicol sodium succinate, up to 1 gm, which is an antibiotic medication used to treat various bacterial infections.
71. HCPCS Code J0725
HCPCS J0725 describes the injection of chorionic gonadotropin, per 1,000 USP units, which is a medication used for the treatment of infertility and certain hormonal disorders.
72. HCPCS Code J0735
HCPCS J0735 describes the injection of clonidine hydrochloride, 1 mg, which is a medication used for the treatment of high blood pressure and certain other conditions.
73. HCPCS Code J0736
HCPCS J0736 describes the injection of clindamycin phosphate, 300 mg, which is an antibiotic medication used to treat various bacterial infections.
74. HCPCS Code J0737
HCPCS J0737 describes the injection of clindamycin phosphate (baxter), not therapeutically equivalent to J0736, 300 mg, which is an antibiotic medication used to treat various bacterial infections.
75. HCPCS Code J0739
HCPCS J0739 describes the injection of cabotegravir, 1 mg, which is a medication used for the prevention of HIV infection.
76. HCPCS Code J0740
HCPCS J0740 describes the injection of cidofovir, 375 mg, which is an antiviral medication used to treat certain viral infections.
77. HCPCS Code J0741
HCPCS J0741 describes the injection of cabotegravir and rilpivirine, 2mg/3mg, which is a medication used for the treatment of HIV infection.
78. HCPCS Code J0742
HCPCS J0742 describes the injection of imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg, which is an antibiotic medication used to treat various bacterial infections.
79. HCPCS Code J0743
HCPCS J0743 describes the injection of cilastatin sodium; imipenem, per 250 mg, which is an antibiotic medication used to treat various bacterial infections.
80. HCPCS Code J0744
HCPCS J0744 describes the injection of ciprofloxacin for intravenous infusion, 200 mg, which is an antibiotic medication used to treat various bacterial infections.
81. HCPCS Code J0745
HCPCS J0745 describes the injection of codeine phosphate, per 30 mg, which is a medication used for the treatment of moderate to severe pain and cough.
82. HCPCS Code J0750
HCPCS J0750 describes the oral medication combination of Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, which is used for HIV pre-exposure prophylaxis.
83. HCPCS Code J0751
HCPCS J0751 describes the oral medication combination of Emtricitabine 200mg and tenofovir alafenamide 25mg, which is used for HIV pre-exposure prophylaxis.
84. HCPCS Code J0770
HCPCS J0770 describes the injection of colistimethate sodium, up to 150 mg, which is an antibiotic medication used to treat certain bacterial infections.
85. HCPCS Code J0775
HCPCS J0775 describes the injection of collagenase, clostridium histolyticum, 0.01 mg, which is a medication used for the treatment of Dupuytren’s contracture and Peyronie’s disease.
86. HCPCS Code J0780
HCPCS J0780 describes the injection of prochlorperazine, up to 10 mg, which is a medication used for the treatment of nausea and vomiting.
87. HCPCS Code J0791
HCPCS J0791 describes the injection of crizanlizumab-tmca, 5 mg, which is a medication used for the prevention of vaso-occlusive crises in sickle cell disease.
88. HCPCS Code J0795
HCPCS J0795 describes the injection of corticorelin ovine triflutate, 1 microgram, which is a medication used for the diagnosis of certain hormonal disorders.
89. HCPCS Code J0799
HCPCS J0799 describes a non-specific code for FDA approved prescription drugs used for HIV pre-exposure prophylaxis.
90. HCPCS Code J0801
HCPCS J0801 describes the injection of corticotropin (acthar gel), up to 40 units, which is a medication used for the treatment of certain inflammatory and autoimmune conditions.
91. HCPCS Code J0802
HCPCS J0802 describes the injection of corticotropin (ani), up to 40 units, which is a medication used for the treatment of certain inflammatory and autoimmune conditions.
92. HCPCS Code J0834
HCPCS J0834 describes the injection of cosyntropin, 0.25 mg, which is a medication used for the diagnosis of certain hormonal disorders.
93. HCPCS Code J0840
HCPCS J0840 describes the injection of crotalidae polyvalent immune FAB(Ovine), up to 1 gram, which is a medication used for the treatment of snakebite envenomation.
94. HCPCS Code J0841
HCPCS J0841 describes the injection of crotalidae immune f(ab’)2 (equine), 120 mg, which is a medication used for the treatment of snakebite envenomation.
95. HCPCS Code J0850
HCPCS J0850 describes the injection of cytomegalovirus immune globulin intravenous (human), per vial, which is a medication used for the prevention and treatment of cytomegalovirus infection.
96. HCPCS Code J0873
HCPCS J0873 describes the injection of daptomycin (xellia), not therapeutically equivalent to J0878, 1 mg, which is an antibiotic medication used to treat certain bacterial infections.
97. HCPCS Code J0874
HCPCS J0874 describes the injection of daptomycin (baxter), not therapeutically equivalent to J0878, 1 mg, which is an antibiotic medication used to treat certain bacterial infections.
98. HCPCS Code J0875
HCPCS J0875 describes the injection of dalbavancin, 5mg, which is an antibiotic medication used to treat certain bacterial infections.
99. HCPCS Code J0877
HCPCS J0877 describes the injection of daptomycin (hospira), not therapeutically equivalent to J0878, 1 mg, which is an antibiotic medication used to treat certain bacterial infections.
100. HCPCS Code J0878
HCPCS J0878 describes the injection of daptomycin, 1 mg, which is an antibiotic medication used to treat certain bacterial infections.
101. HCPCS Code J0879
HCPCS J0879 describes the injection of difelikefalin, 0.1 microgram, which is a medication used for the treatment of itching associated with chronic kidney disease on dialysis.
102. HCPCS Code J0881
HCPCS J0881 describes the injection of darbepoetin alfa, 1 microgram, which is a medication used for the treatment of anemia associated with chronic kidney disease and certain other conditions.
103. HCPCS Code J0882
HCPCS J0882 describes the injection of darbepoetin alfa, 1 microgram, which is a medication used for the treatment of anemia associated with chronic kidney disease on dialysis.
104. HCPCS Code J0883
HCPCS J0883 describes the injection of argatroban, 1 mg, which is a medication used for the treatment of certain blood clotting disorders.
105. HCPCS Code J0884
HCPCS J0884 describes the injection of argatroban, 1 mg, which is a medication used for the treatment of certain blood clotting disorders in patients with chronic kidney disease on dialysis.
106. HCPCS Code J0885
HCPCS J0885 describes the injection of epoetin alfa, 1000 units, which is a medication used for the treatment of anemia associated with chronic kidney disease and certain other conditions.
107. HCPCS Code J0887
HCPCS J0887 describes the injection of epoetin beta, 1 microgram, which is a medication used for the treatment of anemia associated with chronic kidney disease on dialysis.
108. HCPCS Code J0888
HCPCS J0888 describes the injection of epoetin beta, 1 microgram, which is a medication used for the treatment of anemia associated with chronic kidney disease and certain other conditions.
109. HCPCS Code J0889
HCPCS J0889 describes the oral medication Daprodustat, 1 mg, which is used for the treatment of anemia associated with chronic kidney disease on dialysis.
110. HCPCS Code J0890
HCPCS J0890 describes the injection of peginesatide, 0.1 mg, which is a medication used for the treatment of anemia associated with chronic kidney disease on dialysis.
111. HCPCS Code J0891
HCPCS J0891 describes the injection of argatroban (accord), not therapeutically equivalent to J0883, 1 mg, which is a medication used for the treatment of certain blood clotting disorders.
112. HCPCS Code J0892
HCPCS J0892 describes the injection of argatroban (accord), not therapeutically equivalent to J0884, 1 mg, which is a medication used for the treatment of certain blood clotting disorders in patients with chronic kidney disease on dialysis.
113. HCPCS Code J0893
HCPCS J0893 describes the injection of decitabine (sun pharma), not therapeutically equivalent to J0894, 1 mg, which is a medication used for the treatment of certain types of cancer.
114. HCPCS Code J0894
HCPCS J0894 describes the injection of decitabine, 1 mg, which is a medication used for the treatment of certain types of cancer.
115. HCPCS Code J0895
HCPCS J0895 describes the injection of deferoxamine mesylate, 500 mg, which is a medication used for the treatment of iron overload.
116. HCPCS Code J0896
HCPCS J0896 describes the injection of luspatercept-aamt, 0.25 mg, which is a medication used for the treatment of anemia associated with certain blood disorders.
117. HCPCS Code J0897
HCPCS J0897 describes the injection of denosumab, 1 mg, which is a medication used for the treatment of osteoporosis and certain types of cancer.
118. HCPCS Code J0898
HCPCS J0898 describes the injection of argatroban (auromedics), not therapeutically equivalent to J0883, 1 mg, which is a medication used for the treatment of certain blood clotting disorders.
119. HCPCS Code J0899
HCPCS J0899 describes the injection of argatroban (auromedics), not therapeutically equivalent to J0884, 1 mg, which is a medication used for the treatment of certain blood clotting disorders in patients with chronic kidney disease on dialysis.
120. HCPCS Code J0945
HCPCS J0945 describes the injection of brompheniramine maleate, per 10 mg, which is an antihistamine medication used for the treatment of allergic reactions and symptoms.
121. HCPCS Code J0184
HCPCS J0184 describes the injection of amisulpride, 1 mg, which is a medication used for the treatment of certain mental health conditions.
122. HCPCS Code J0185
HCPCS J0185 describes the injection of aprepitant, 1 mg, which is a medication used for the prevention of nausea and vomiting associated with chemotherapy.
123. HCPCS Code J0190
HCPCS J0190 describes the injection of biperiden lactate, per 5 mg, which is a medication used for the treatment of Parkinson’s disease and certain other conditions.
124. HCPCS Code J0200
HCPCS J0200 describes the injection of alatrofloxacin mesylate, 100 mg, which is an antibiotic medication used to treat various bacterial infections.
125. HCPCS Code J0202
HCPCS J0202 describes the injection of alemtuzumab, 1 mg, which is a medication used for the treatment of certain types of cancer and multiple sclerosis.
126. HCPCS Code J0205
HCPCS J0205 describes the injection of alglucerase, per 10 units, which is a medication used for the treatment of Gaucher disease.
127. HCPCS Code J0206
HCPCS J0206 describes the injection of allopurinol sodium, 1 mg, which is a medication used for the treatment of gout and certain other conditions.
128. HCPCS Code J0207
HCPCS J0207 describes the injection of amifostine, 500 mg, which is a medication used to protect against certain side effects of chemotherapy and radiation therapy.
129. HCPCS Code J0208
HCPCS J0208 describes the injection of sodium thiosulfate, 100 mg, which is a medication used for the treatment of certain types of cyanide poisoning.
130. HCPCS Code J0210
HCPCS J0210 describes the injection of methyldopate HCl, up to 250 mg, which is a medication used for the treatment of high blood pressure.
131. HCPCS Code J1000
HCPCS J1000 describes the injection of depo-estradiol cypionate, up to 5 mg, which is a hormone medication used for the treatment of certain hormonal disorders.
132. HCPCS Code J1020
HCPCS J1020 describes the injection of methylprednisolone acetate, 20 mg, which is a corticosteroid medication used for the treatment of inflammation and certain other conditions.
133. HCPCS Code J1030
HCPCS J1030 describes the injection of methylprednisolone acetate, 40 mg, which is a corticosteroid medication used for the treatment of inflammation and certain other conditions.
134. HCPCS Code J1040
HCPCS J1040 describes the injection of methylprednisolone acetate, 80 mg, which is a corticosteroid medication used for the treatment of inflammation and certain other conditions.
135. HCPCS Code J1050
HCPCS J1050 describes the injection of medroxyprogesterone acetate, 1 mg, which is a hormone medication used for birth control and the treatment of certain hormonal disorders.
136. HCPCS Code J1071
HCPCS J1071 describes the injection of testosterone cypionate, 1 mg, which is a hormone medication used for the treatment of low testosterone levels.
137. HCPCS Code J1094
HCPCS J1094 describes the injection of dexamethasone acetate, 1 mg, which is a corticosteroid medication used for the treatment of inflammation and certain other conditions.
138. HCPCS Code J1095
HCPCS J1095 describes the injection of dexamethasone 9 percent, intraocular, 1 microgram, which is a corticosteroid medication used for the treatment of certain eye conditions.
139. HCPCS Code J1096
HCPCS J1096 describes the lacrimal ophthalmic insert of Dexamethasone, 0.1 mg, which is a corticosteroid medication used for the treatment of certain eye conditions.
140. HCPCS Code J1097
HCPCS J1097 describes the injection of phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml, which is a medication used during certain eye surgeries.
141. HCPCS Code J1100
HCPCS J1100 describes the injection of dexamethasone sodium phosphate, 1 mg, which is a corticosteroid medication used for the treatment of inflammation and certain other conditions.
142. HCPCS Code J1105
HCPCS J1105 describes the injection of diphenhydramine HCl, up to 50 mg, which is an antihistamine medication used for the treatment of allergic reactions and symptoms.
143. HCPCS Code J1106
HCPCS J1106 describes the oral medication combination of Dexmedetomidine, 1 mcg, which is used for sedation during certain medical procedures.
144. HCPCS Code J1110
HCPCS J1110 describes the injection of dihydroergotamine mesylate, per 1 mg, which is a medication used for the treatment of migraines and certain other conditions.
145. HCPCS Code J1120
HCPCS J1120 describes the injection of acetazolamide sodium, up to 500 mg, which is a medication used for the treatment of glaucoma and certain other conditions.
146. HCPCS Code J1130
HCPCS J1130 describes the injection of diclofenac sodium, 0.5 mg, which is a nonsteroidal anti-inflammatory medication used for the treatment of pain and inflammation.
147. HCPCS Code J1160
HCPCS J1160 describes the injection of digoxin, up to 0.5 mg, which is a medication used for the treatment of certain heart conditions.
148. HCPCS Code J1162
HCPCS J1162 describes the injection of digoxin immune FAB(Ovine), per vial, which is a medication used for the treatment of digoxin toxicity.
149. HCPCS Code J1165
HCPCS J1165 describes the injection of phenytoin sodium, per 50 mg, which is an anticonvulsant medication used for the treatment of seizures.
150. HCPCS Code J1170
HCPCS J1170 describes the injection of hydromorphone, up to 4 mg, which is a medication used for the treatment of moderate to severe pain.
151. HCPCS Code J1180
HCPCS J1180 describes the injection of dyphylline, up to 500 mg, which is a medication used for the treatment of asthma and certain other respiratory conditions.
152. HCPCS Code J1190
HCPCS J1190 describes the injection of dexrazoxane hydrochloride, per 250 mg, which is a medication used to prevent certain side effects of chemotherapy.
153. HCPCS Code J1200
HCPCS J1200 describes the injection of diphenhydramine HCl, up to 50 mg, which is an antihistamine medication used for the treatment of allergic reactions and symptoms.
154. HCPCS Code J1201
HCPCS J1201 describes the injection of cetirizine hydrochloride, 0.5 mg, which is an antihistamine medication used for the treatment of allergic reactions and symptoms.
155. HCPCS Code J1205
HCPCS J1205 describes the injection of chlorothiazide sodium, per 500 mg, which is a medication used for the treatment of high blood pressure and certain other conditions.
156. HCPCS Code J1212
HCPCS J1212 describes the injection of DMSO (dimethyl sulfoxide), 50%, 50 ml, which is a medication used for the treatment of certain bladder conditions and pain relief.
157. HCPCS Code J1230
HCPCS J1230 describes the injection of methadone HCl, up to 10 mg, which is a medication used for the treatment of opioid dependence and pain management.
158. HCPCS Code J1240
HCPCS J1240 describes the injection of dimenhydrinate, up to 50 mg, which is an antihistamine medication used for the treatment of motion sickness and nausea.
159. HCPCS Code J1245
HCPCS J1245 describes the injection of dipyridamole, per 10 mg, which is a medication used for the prevention of blood clots and the treatment of certain heart conditions.
160. HCPCS Code J1250
HCPCS J1250 describes the injection of Dobutamine hydrochloride, per 250 mg, which is a medication used for the treatment of certain heart conditions.
161. HCPCS Code J1260
HCPCS J1260 describes the injection of dolasetron mesylate, 10 mg, which is a medication used for the prevention and treatment of nausea and vomiting associated with chemotherapy and surgery.
162. HCPCS Code J1265
HCPCS J1265 describes the injection of dopamine HCl, 40 mg, which is a medication used for the treatment of certain heart conditions and low blood pressure.
163. HCPCS Code J1267
HCPCS J1267 describes the injection of doripenem, 10 mg, which is an antibiotic medication used to treat various bacterial infections.
164. HCPCS Code J1270
HCPCS J1270 describes the injection of doxercalciferol, 1 mcg, which is a medication used for the treatment of certain types of vitamin D deficiency and certain kidney conditions.
165. HCPCS Code J1290
HCPCS J1290 describes the injection of ecallantide, 1 mg, which is a medication used for the treatment of hereditary angioedema attacks.
166. HCPCS Code J1300
HCPCS J1300 describes the injection of eculizumab, 10 mg, which is a medication used for the treatment of certain blood disorders and kidney conditions.
167. HCPCS Code J1301
HCPCS J1301 describes the injection of edaravone, 1 mg, which is a medication used for the treatment of amyotrophic lateral sclerosis (ALS).
168. HCPCS Code J1302
HCPCS J1302 describes the injection of sutimlimab-jome, 10 mg, which is a medication used for the treatment of cold agglutinin disease.
169. HCPCS Code J1303
HCPCS J1303 describes the injection of ravulizumab-cwvz, 10 mg, which is a medication used for the treatment of certain blood disorders.
170. HCPCS Code J1304
HCPCS J1304 describes the injection of tofersen, 1 mg, which is a medication used for the treatment of certain genetic disorders.
171. HCPCS Code J1305
HCPCS J1305 describes the injection of evinacumab-dgnb, 5mg, which is a medication used for the treatment of certain genetic disorders.
172. HCPCS Code J1320
HCPCS J1320 describes the injection of amitriptyline HCl, up to 20 mg, which is a medication used to treat depression and certain types of pain.
173. HCPCS Code J1322
HCPCS J1322 describes the injection of elosulfase alfa, 1 mg, which is an enzyme replacement therapy used to treat a specific genetic disorder called mucopolysaccharidosis type IVA.
174. HCPCS Code J1324
HCPCS J1324 describes the injection of enfuvirtide, 1 mg, which is an antiviral medication used to treat HIV infection.
175. HCPCS Code J1325
HCPCS J1325 describes the injection of epoprostenol, 0.5 mg, which is a medication used to treat pulmonary arterial hypertension.
176. HCPCS Code J1327
HCPCS J1327 describes the injection of eptifibatide, 5 mg, which is a medication used to prevent blood clots in certain medical procedures or conditions.
177. HCPCS Code J1330
HCPCS J1330 describes the injection of ergonovine maleate, up to 0.2 mg, which is a medication used to treat and prevent certain types of bleeding.
178. HCPCS Code J1335
HCPCS J1335 describes the injection of ertapenem sodium, 500 mg, which is an antibiotic used to treat various bacterial infections.
179. HCPCS Code J1364
HCPCS J1364 describes the injection of erythromycin lactobionate, per 500 mg, which is an antibiotic used to treat infections caused by bacteria.
180. HCPCS Code J1380
HCPCS J1380 describes the injection of estradiol valerate, up to 10 mg, which is a hormone medication used for hormone replacement therapy or to treat certain conditions related to hormone imbalance.
181. HCPCS Code J1410
HCPCS J1410 describes the injection of estrogen conjugated, per 25 mg, which is a hormone medication used for hormone replacement therapy or to treat certain conditions related to hormone imbalance.
182. HCPCS Code J1411
HCPCS J1411 describes the injection of etranacogene dezaparvovec-drlb, per therapeutic dose, which is a gene therapy used to treat a specific genetic disorder called hemophilia B.
183. HCPCS Code J1412
HCPCS J1412 describes the injection of valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes, which is a gene therapy used to treat a specific genetic disorder called hemophilia A.
184. HCPCS Code J1413
HCPCS J1413 describes the injection of delandistrogene moxeparvovec-rokl, per therapeutic dose, which is a gene therapy used to treat a specific genetic disorder called adrenoleukodystrophy.
185. HCPCS Code J1426
HCPCS J1426 describes the injection of casimersen, 10 mg, which is a medication used to treat a specific genetic disorder called Duchenne muscular dystrophy.
186. HCPCS Code J1427
HCPCS J1427 describes the injection of viltolarsen, 10 mg, which is a medication used to treat a specific genetic disorder called Duchenne muscular dystrophy.
187. HCPCS Code J1428
HCPCS J1428 describes the injection of eteplirsen, 10 mg, which is a medication used to treat a specific genetic disorder called Duchenne muscular dystrophy.
188. HCPCS Code J1429
HCPCS J1429 describes the injection of golodirsen, 10 mg, which is a medication used to treat a specific genetic disorder called Duchenne muscular dystrophy.
189. HCPCS Code J1430
HCPCS J1430 describes the injection of ethanolamine oleate, 100 mg, which is a medication used to treat certain types of blood vessel conditions.
190. HCPCS Code J1435
HCPCS J1435 describes the injection of estrone, per 1 mg, which is a hormone medication used for hormone replacement therapy or to treat certain conditions related to hormone imbalance.
191. HCPCS Code J1436
HCPCS J1436 describes the injection of etidronate disodium, per 300 mg, which is a medication used to treat certain bone conditions.
192. HCPCS Code J1437
HCPCS J1437 describes the injection of ferric derisomaltose, 10 mg, which is an iron replacement therapy used to treat iron deficiency anemia.
193. HCPCS Code J1438
HCPCS J1438 describes the injection of etanercept, 25 mg, which is a medication used to treat autoimmune diseases such as rheumatoid arthritis and psoriasis.
194. HCPCS Code J1439
HCPCS J1439 describes the injection of ferric carboxymaltose, 1 mg, which is an iron replacement therapy used to treat iron deficiency anemia.
195. HCPCS Code J1440
HCPCS J1440 describes the injection of fecal microbiota, live – jslm, 1 ml, which is a treatment used for certain gastrointestinal conditions.
196. HCPCS Code J1442
HCPCS J1442 describes the injection of filgrastim (G-CSF), excludes biosimilars, 1 microgram, which is a medication used to stimulate the production of white blood cells.
197. HCPCS Code J1443
HCPCS J1443 describes the injection of ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron, which is an iron replacement therapy used in patients on hemodialysis.
198. HCPCS Code J1444
HCPCS J1444 describes the injection of ferric pyrophosphate citrate powder, 0.1 mg of iron, which is an iron replacement therapy used in patients on hemodialysis.
199. HCPCS Code J1445
HCPCS J1445 describes the injection of ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron, which is an iron replacement therapy used in patients on hemodialysis.
200. HCPCS Code J1447
HCPCS J1447 describes the injection of tbo-filgrastim, 1 microgram, which is a medication used to stimulate the production of white blood cells.
201. HCPCS Code J1448
HCPCS J1448 describes the injection of trilaciclib, 1mg, which is a medication used to reduce the risk of chemotherapy-induced myelosuppression.
202. HCPCS Code J1449
HCPCS J1449 describes the injection of eflapegrastim-xnst, 0.1 mg, which is a medication used to stimulate the production of white blood cells.
203. HCPCS Code J1450
HCPCS J1450 describes the injection of fluconazole, 200 mg, which is an antifungal medication used to treat fungal infections.
204. HCPCS Code J1451
HCPCS J1451 describes the injection of fomepizole, 15 mg, which is a medication used to treat poisoning from certain substances.
205. HCPCS Code J1452
HCPCS J1452 describes the injection of fomivirsen sodium, intraocular, 1.65 mg, which is a medication used to treat a specific eye infection caused by a virus.
206. HCPCS Code J1453
HCPCS J1453 describes the injection of fosaprepitant, 1 mg, which is a medication used to prevent nausea and vomiting caused by chemotherapy.
207. HCPCS Code J1454
HCPCS J1454 describes the injection of fosnetupitant 235 mg and palonosetron 0.25 mg, which is a medication used to prevent nausea and vomiting caused by chemotherapy.
208. HCPCS Code J1455
HCPCS J1455 describes the injection of foscarnet sodium, per 1000 mg, which is an antiviral medication used to treat certain viral infections.
209. HCPCS Code J1456
HCPCS J1456 describes the injection of fosaprepitant (teva), not therapeutically equivalent to J1453, 1 mg, which is a medication used to prevent nausea and vomiting caused by chemotherapy.
210. HCPCS Code J1457
HCPCS J1457 describes the injection of gallium nitrate, 1 mg, which is a medication used to treat high calcium levels in the blood.
211. HCPCS Code J1458
HCPCS J1458 describes the injection of galsulfase, 1 mg, which is an enzyme replacement therapy used to treat a specific genetic disorder called mucopolysaccharidosis type VI.
212. HCPCS Code J1459
HCPCS J1459 describes the injection of immune globulin (Privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
213. HCPCS Code J1460
HCPCS J1460 describes the injection of gamma globulin, intramuscular, 1 cc, which is a medication used to boost the immune system and treat certain immune disorders.
214. HCPCS Code J1551
HCPCS J1551 describes the injection of immune globulin (cutaquig), 100 mg, which is a medication used to boost the immune system and treat certain immune disorders.
215. HCPCS Code J1554
HCPCS J1554 describes the injection of immune globulin (asceniv), 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
216. HCPCS Code J1555
HCPCS J1555 describes the injection of immune globulin (cuvitru), 100 mg, which is a medication used to boost the immune system and treat certain immune disorders.
217. HCPCS Code J1556
HCPCS J1556 describes the injection of immune globulin (bivigam), 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
218. HCPCS Code J1557
HCPCS J1557 describes the injection of immune globulin, (Gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
219. HCPCS Code J1558
HCPCS J1558 describes the injection of immune globulin (xembify), 100 mg, which is a medication used to boost the immune system and treat certain immune disorders.
220. HCPCS Code J1559
HCPCS J1559 describes the injection of immune globulin (Hizentra), 100 mg, which is a medication used to boost the immune system and treat certain immune disorders.
221. HCPCS Code J1560
HCPCS J1560 describes the injection of gamma globulin, intramuscular, over 10 cc, which is a medication used to boost the immune system and treat certain immune disorders.
222. HCPCS Code J1561
HCPCS J1561 describes the injection of immune globulin, (Gamunex-C/Gammaked), non-lyophilized (e.g., liquid), 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
223. HCPCS Code J1562
HCPCS J1562 describes the injection of immune globulin (Vivaglobin), 100 mg, which is a medication used to boost the immune system and treat certain immune disorders.
224. HCPCS Code J1566
HCPCS J1566 describes the injection of immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
225. HCPCS Code J1568
HCPCS J1568 describes the injection of immune globulin, (Octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
226. HCPCS Code J1569
HCPCS J1569 describes the injection of immune globulin, (Gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
227. HCPCS Code J1570
HCPCS J1570 describes the injection of ganciclovir sodium, 500 mg, which is an antiviral medication used to treat certain viral infections.
228. HCPCS Code J1571
HCPCS J1571 describes the injection of hepatitis B immune globulin (HepaGam B), intramuscular, 0.5 ml, which is a medication used to prevent hepatitis B infection.
229. HCPCS Code J1572
HCPCS J1572 describes the injection of immune globulin, (Flebogamma/Flebogamma Dif), intravenous, non-lyophilized (e.g., liquid), 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
230. HCPCS Code J1573
HCPCS J1573 describes the injection of hepatitis B immune globulin (HepaGam B), intravenous, 0.5 ml, which is a medication used to prevent hepatitis B infection.
231. HCPCS Code J0215
HCPCS J0215 describes the injection of alefacept, 0.5 mg, which is a medication used to treat certain autoimmune diseases such as psoriasis.
232. HCPCS Code J0216
HCPCS J0216 describes the injection of alfentanil hydrochloride, 500 micrograms, which is a medication used for anesthesia and pain management.
233. HCPCS Code J0217
HCPCS J0217 describes the injection of velmanase alfa-tycv, 1 mg, which is an enzyme replacement therapy used to treat a specific genetic disorder called alpha-mannosidosis.
234. HCPCS Code J0218
HCPCS J0218 describes the injection of olipudase alfa-rpcp, 1 mg, which is an enzyme replacement therapy used to treat a specific genetic disorder called acid sphingomyelinase deficiency.
235. HCPCS Code J0219
HCPCS J0219 describes the injection of avalglucosidase alfa-ngpt, 4 mg, which is an enzyme replacement therapy used to treat a specific genetic disorder called Pompe disease.
236. HCPCS Code J0220
HCPCS J0220 describes the injection of alglucosidase alfa, 10 mg, not otherwise specified, which is an enzyme replacement therapy used to treat a specific genetic disorder called Pompe disease.
237. HCPCS Code J0221
HCPCS J0221 describes the injection of alglucosidase alfa, (Lumizyme), 10 mg, which is an enzyme replacement therapy used to treat a specific genetic disorder called Pompe disease.
238. HCPCS Code J0222
HCPCS J0222 describes the injection of Patisiran, 0.1 mg, which is a medication used to treat a specific genetic disorder called hereditary transthyretin-mediated amyloidosis.
239. HCPCS Code J0223
HCPCS J0223 describes the injection of givosiran, 0.5 mg, which is a medication used to treat a specific genetic disorder called acute hepatic porphyria.
240. HCPCS Code J0224
HCPCS J0224 describes the injection of lumasiran, 0.5 mg, which is a medication used to treat a specific genetic disorder called primary hyperoxaluria type 1.
241. HCPCS Code J1574
HCPCS J1574 describes the injection of ganciclovir sodium (exela) not therapeutically equivalent to J1570, 500 mg, which is an antiviral medication used to treat certain viral infections.
242. HCPCS Code J1575
HCPCS J1575 describes the injection of immune globulin/hyaluronidase, (HYQVIA), 100 mg immuneglobulin, which is a medication used to boost the immune system and treat certain immune disorders.
243. HCPCS Code J1576
HCPCS J1576 describes the injection of immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
244. HCPCS Code J1580
HCPCS J1580 describes the injection of garamycin, gentamicin, up to 80 mg, which is an antibiotic used to treat various bacterial infections.
245. HCPCS Code J1595
HCPCS J1595 describes the injection of glatiramer acetate, 20 mg, which is a medication used to treat multiple sclerosis.
246. HCPCS Code J1596
HCPCS J1596 describes the injection of glycopyrrolate, 0.1 mg, which is a medication used to reduce saliva production and treat certain medical conditions.
247. HCPCS Code J1599
HCPCS J1599 describes the injection of immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg, which is a medication used to boost the immune system and treat certain immune disorders.
248. HCPCS Code J1600
HCPCS J1600 describes the injection of gold sodium thiomalate, up to 50 mg, which is a medication used to treat rheumatoid arthritis.
249. HCPCS Code J1602
HCPCS J1602 describes the injection of golimumab, 1 mg, for intravenous use, which is a medication used to treat autoimmune diseases such as rheumatoid arthritis and psoriatic arthritis.
250. HCPCS Code J1610
HCPCS J1610 describes the injection of glucagon hydrochloride, per 1 mg, which is a medication used to treat severe low blood sugar.
251. HCPCS Code J1611
HCPCS J1611 describes the injection of glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to J1610, per 1 mg, which is a medication used to treat severe low blood sugar.
252. HCPCS Code J1620
HCPCS J1620 describes the injection of gonadorelin hydrochloride, per 100 mcg, which is a medication used to stimulate the production of certain hormones.
253. HCPCS Code J1626
HCPCS J1626 describes the injection of granisetron hydrochloride, 100 mcg, which is a medication used to prevent nausea and vomiting caused by chemotherapy.
254. HCPCS Code J1627
HCPCS J1627 describes the injection of granisetron, extended-release, 0.1 mg, which is a medication used to prevent nausea and vomiting caused by chemotherapy.
255. HCPCS Code J1628
HCPCS J1628 describes the injection of guselkumab, 1 mg, which is a medication used to treat certain autoimmune diseases such as psoriasis.
256. HCPCS Code J1630
HCPCS J1630 describes the injection of haloperidol, up to 5 mg, which is a medication used to treat certain mental disorders.
257. HCPCS Code J1631
HCPCS J1631 describes the injection of haloperidol decanoate, per 50 mg, which is a long-acting medication used to treat certain mental disorders.
258. HCPCS Code J1632
HCPCS J1632 describes the injection of brexanolone, 1 mg, which is a medication used to treat postpartum depression.
259. HCPCS Code J1640
HCPCS J1640 describes the injection of hemin, 1 mg, which is a medication used to treat certain types of porphyria.
260. HCPCS Code J1642
HCPCS J1642 describes the injection of heparin sodium, (heparin lock flush), per 10 units, which is a medication used to prevent blood clots in certain medical procedures.
261. HCPCS Code J1643
HCPCS J1643 describes the injection of heparin sodium (pfizer), not therapeutically equivalent to J1644, per 1000 units, which is a medication used to prevent blood clots.
262. HCPCS Code J1644
HCPCS J1644 describes the injection of heparin sodium, per 1000 units, which is a medication used to prevent blood clots.
263. HCPCS Code J1645
HCPCS J1645 describes the injection of dalteparin sodium, per 2500 IU, which is a medication used to prevent blood clots.
264. HCPCS Code J1650
HCPCS J1650 describes the injection of enoxaparin sodium, 10 mg, which is a medication used to prevent blood clots.
265. HCPCS Code J1652
HCPCS J1652 describes the injection of fondaparinux sodium, 0.5 mg, which is a medication used to prevent blood clots.
266. HCPCS Code J1655
HCPCS J1655 describes the injection of tinzaparin sodium, 1000 IU, which is a medication used to prevent blood clots.
267. HCPCS Code J1670
HCPCS J1670 describes the injection of tetanus immune globulin, human, up to 250 units, which is a medication used to prevent tetanus infection.
268. HCPCS Code J1675
HCPCS J1675 describes the injection of histrelin acetate, 10 micrograms, which is a medication used to treat certain hormone-related conditions.
269. HCPCS Code J1700
HCPCS J1700 describes the injection of hydrocortisone acetate, up to 25 mg, which is a medication used to treat certain inflammatory conditions.
270. HCPCS Code J1710
HCPCS J1710 describes the injection of hydrocortisone sodium phosphate, up to 50 mg, which is a medication used to treat certain inflammatory conditions.
271. HCPCS Code J1720
HCPCS J1720 describes the injection of hydrocortisone sodium succinate, up to 100 mg, which is a medication used to treat certain inflammatory conditions.
272. HCPCS Code J1726
HCPCS J1726 describes the injection of hydroxyprogesterone caproate, (makena), 10 mg, which is a medication used to prevent preterm birth in certain high-risk pregnancies.
273. HCPCS Code J1729
HCPCS J1729 describes the injection of hydroxyprogesterone caproate, not otherwise specified, 10 mg, which is a medication used to prevent preterm birth in certain high-risk pregnancies.
274. HCPCS Code J1730
HCPCS J1730 describes the injection of diazoxide, up to 300 mg, which is a medication used to treat certain medical conditions such as low blood sugar.
275. HCPCS Code J1738
HCPCS J1738 describes the injection of meloxicam, 1 mg, which is a medication used to treat pain and inflammation.
276. HCPCS Code J1740
HCPCS J1740 describes the injection of ibandronate sodium, 1 mg, which is a medication used to treat osteoporosis.
277. HCPCS Code J1741
HCPCS J1741 describes the injection of ibuprofen, 100 mg, which is a medication used to treat pain and inflammation.
278. HCPCS Code J1742
HCPCS J1742 describes the injection of ibutilide fumarate, 1 mg, which is a medication used to treat certain heart rhythm disorders.
279. HCPCS Code J1743
HCPCS J1743 describes the injection of idursulfase, 1 mg, which is an enzyme replacement therapy used to treat a specific genetic disorder called mucopolysaccharidosis type II.
280. HCPCS Code J1744
HCPCS J1744 describes the injection of icatibant, 1 mg, which is a medication used to treat hereditary angioedema.
281. HCPCS Code J1745
HCPCS J1745 describes the injection of infliximab, excludes biosimilar, 10 mg, which is a medication used to treat autoimmune diseases such as rheumatoid arthritis and Crohn’s disease.
282. HCPCS Code J1746
HCPCS J1746 describes the injection of ibalizumab-uiyk, 10 mg, which is a medication used to treat HIV infection.
283. HCPCS Code J1747
HCPCS J1747 describes the injection of spesolimab-sbzo, 1 mg, which is a medication used to treat certain autoimmune diseases.
284. HCPCS Code J1750
HCPCS J1750 describes the injection of iron dextran, 50 mg, which is an iron replacement therapy used to treat iron deficiency anemia.
285. HCPCS Code J1756
HCPCS J1756 describes the injection of iron sucrose, 1 mg, which is an iron replacement therapy used to treat iron deficiency anemia.
286. HCPCS Code J1786
HCPCS J1786 describes the injection of imiglucerase, 10 units, which is an enzyme replacement therapy used to treat a specific genetic disorder called Gaucher disease.
287. HCPCS Code J1790
HCPCS J1790 describes the injection of droperidol, up to 5 mg, which is a medication used to treat certain mental disorders and prevent nausea and vomiting.
288. HCPCS Code J1800
HCPCS J1800 describes the injection of propranolol HCl, up to 1 mg, which is a medication used to treat high blood pressure and certain heart conditions.
289. HCPCS Code J1805
HCPCS J1805 describes the injection of esmolol hydrochloride, 10 mg, which is a medication used to treat certain heart conditions.
290. HCPCS Code J1806
HCPCS J1806 describes the injection of esmolol hydrochloride (wg critical care) not therapeutically equivalent to J1805, 10 mg, which is a medication used to treat certain heart conditions.
291. HCPCS Code J1810
HCPCS J1810 describes the injection of droperidol and fentanyl Citrate, up to 2 ml ampule, which is a medication used for anesthesia and pain management.
292. HCPCS Code J1811
HCPCS J1811 describes the insulin (fiasp) for administration through DME (i.e., insulin pump) per 50 units, which is a medication used to treat diabetes.
293. HCPCS Code J1812
HCPCS J1812 describes the insulin (fiasp), per 5 units, which is a medication used to treat diabetes.
294. HCPCS Code J1813
HCPCS J1813 describes the insulin (lyumjev) for administration through DME (i.e., insulin pump) per 50 units, which is a medication used to treat diabetes.
295. HCPCS Code J1814
HCPCS J1814 describes the insulin (lyumjev), per 5 units, which is a medication used to treat diabetes.
296. HCPCS Code J1815
HCPCS J1815 describes the injection of insulin, per 5 units, which is a medication used to treat diabetes.
297. HCPCS Code J1817
HCPCS J1817 describes the insulin for administration through DME (i.e., insulin pump) per 50 units, which is a medication used to treat diabetes.
298. HCPCS Code J1823
HCPCS J1823 describes the injection of inebilizumab-cdon, 1 mg.
299. HCPCS Code J1826
HCPCS J1826 describes the injection of interferon beta-1a, 30 mcg.
300. HCPCS Code J1830
HCPCS J1830 describes the injection of interferon beta-1b, 0.25 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered).
301. HCPCS Code J1833
HCPCS J1833 describes the injection of isavuconazonium, 1 mg.
302. HCPCS Code J1835
HCPCS J1835 describes the injection of itraconazole, 50 mg.
303. HCPCS Code J1836
HCPCS J1836 describes the injection of metronidazole, 10 mg.
304. HCPCS Code J1840
HCPCS J1840 describes the injection of kanamycin sulfate, up to 500 mg.
305. HCPCS Code J1850
HCPCS J1850 describes the injection of kanamycin sulfate, up to 75 mg.
306. HCPCS Code J1885
HCPCS J1885 describes the injection of ketorolac tromethamine, per 15 mg.
307. HCPCS Code J1890
HCPCS J1890 describes the injection of cephalothin sodium, up to 1 gram.
308. HCPCS Code J1920
HCPCS J1920 describes the injection of labetalol hydrochloride, 5 mg.
309. HCPCS Code J1921
HCPCS J1921 describes the injection of labetalol hydrochloride (hikma) not therapeutically equivalent to J1920, 5 mg.
310. HCPCS Code J1930
HCPCS J1930 describes the injection of lanreotide, 1 mg.
311. HCPCS Code J1931
HCPCS J1931 describes the injection of laronidase, 0.1 mg.
312. HCPCS Code J1932
HCPCS J1932 describes the injection of lanreotide (cipla), 1 mg.
313. HCPCS Code J1939
HCPCS J1939 describes the injection of bumetanide, 0.5 mg.
314. HCPCS Code J1940
HCPCS J1940 describes the injection of furosemide, up to 20 mg.
315. HCPCS Code J1941
HCPCS J1941 describes the injection of furosemide (furoscix), 20 mg.
316. HCPCS Code J1943
HCPCS J1943 describes the injection of aripiprazole lauroxil (aristada initio), 1 mg.
317. HCPCS Code J1944
HCPCS J1944 describes the injection of aripiprazole lauroxil (aristada), 1 mg.
318. HCPCS Code J1945
HCPCS J1945 describes the injection of lepirudin, 50 mg.
319. HCPCS Code J1950
HCPCS J1950 describes the injection of leuprolide acetate (for depot suspension), per 3.75 mg.
320. HCPCS Code J1951
HCPCS J1951 describes the injection of leuprolide acetate for depot suspension (fensolvi), 0.25 mg.
321. HCPCS Code J1952
HCPCS J1952 describes the injectable leuprolide, camcevi, 1 mg.
322. HCPCS Code J1953
HCPCS J1953 describes the injection of levetiracetam, 10 mg.
323. HCPCS Code J1954
HCPCS J1954 describes the injection of leuprolide acetate for depot suspension (cipla), 7.5 mg.
324. HCPCS Code J1955
HCPCS J1955 describes the injection of levocarnitine, per 1 gm.
325. HCPCS Code J1956
HCPCS J1956 describes the injection of levofloxacin, 250 mg.
326. HCPCS Code J1960
HCPCS J1960 describes the injection of levorphanol tartrate, up to 2 mg.
327. HCPCS Code J1961
HCPCS J1961 describes the injection of lenacapavir, 1 mg.
328. HCPCS Code J1980
HCPCS J1980 describes the injection of hyoscyamine sulfate, up to 0.25 mg.
329. HCPCS Code J1990
HCPCS J1990 describes the injection of chlordiazepoxide HCl, up to 100 mg.
330. HCPCS Code J2001
HCPCS J2001 describes the injection of lidocaine HCl for intravenous infusion, 10 mg.
331. HCPCS Code J2010
HCPCS J2010 describes the injection of lincomycin HCl, up to 300 mg.
332. HCPCS Code J2020
HCPCS J2020 describes the injection of linezolid, 200 mg.
333. HCPCS Code J2021
HCPCS J2021 describes the injection of linezolid (hospira) not therapeutically equivalent to J2020, 200 mg.
334. HCPCS Code J2060
HCPCS J2060 describes the injection of lorazepam, 2 mg.
335. HCPCS Code J2062
HCPCS J2062 describes loxapine for inhalation, 1 mg.
336. HCPCS Code J2150
HCPCS J2150 describes the injection of mannitol, 25% in 50 ml.
337. HCPCS Code J2170
HCPCS J2170 describes the injection of mecasermin, 1 mg.
338. HCPCS Code J2175
HCPCS J2175 describes the injection of meperidine hydrochloride, per 100 mg.
339. HCPCS Code J2180
HCPCS J2180 describes the injection of meperidine and promethazine HCl, up to 50 mg.
340. HCPCS Code J2182
HCPCS J2182 describes the injection of mepolizumab, 1 mg.
341. HCPCS Code J0225
HCPCS J0225 describes the injection of vutrisiran, 1 mg.
342. HCPCS Code J0248
HCPCS J0248 describes the injection of remdesivir, 1 mg.
343. HCPCS Code J0256
HCPCS J0256 describes the injection of alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg.
344. HCPCS Code J0257
HCPCS J0257 describes the injection of alpha 1 proteinase inhibitor (human) (GLASSIA), 10 mg.
345. HCPCS Code J0270
HCPCS J0270 describes the injection of alprostadil, 1.25 mcg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered).
346. HCPCS Code J0275
HCPCS J0275 describes the alprostadil urethral suppository (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered).
347. HCPCS Code J0278
HCPCS J0278 describes the injection of amikacin sulfate, 100 mg.
348. HCPCS Code J0280
HCPCS J0280 describes the injection of aminophyllin, up to 250 mg.
349. HCPCS Code J0282
HCPCS J0282 describes the injection of amiodarone hydrochloride, 30 mg.
350. HCPCS Code J0283
HCPCS J0283 describes the injection of amiodarone hydrochloride (nexterone), 30 mg.
351. HCPCS Code J2184
HCPCS J2184 describes the injection of meropenem (b. braun) not therapeutically equivalent to J2185, 100 mg.
352. HCPCS Code J2185
HCPCS J2185 describes the injection of meropenem, 100 mg.
353. HCPCS Code J2186
HCPCS J2186 describes the injection of meropenem and vaborbactam, 10mg/10mg (20mg).
354. HCPCS Code J2210
HCPCS J2210 describes the injection of methylergonovine maleate, up to 0.2 mg.
355. HCPCS Code J2212
HCPCS J2212 describes the injection of methylnaltrexone, 0.1 mg.
356. HCPCS Code J2247
HCPCS J2247 describes the injection of micafungin sodium (par pharm) not therapeutically equivalent to J2248, 1 mg.
357. HCPCS Code J2248
HCPCS J2248 describes the injection of micafungin sodium, 1 mg.
358. HCPCS Code J2249
HCPCS J2249 describes the injection of remimazolam, 1 mg.
359. HCPCS Code J2250
HCPCS J2250 describes the injection of midazolam hydrochloride, per 1 mg.
360. HCPCS Code J2251
HCPCS J2251 describes the injection of midazolam hydrochloride (wg critical care) not therapeutically equivalent to J2250, per 1 mg.
361. HCPCS Code J2260
HCPCS J2260 describes the injection of milrinone lactate, 5 mg.
362. HCPCS Code J2265
HCPCS J2265 describes the injection of minocycline hydrochloride, 1 mg.
363. HCPCS Code J2270
HCPCS J2270 describes the injection of morphine sulfate, up to 10 mg.
364. HCPCS Code J2272
HCPCS J2272 describes the injection of morphine sulfate (fresenius kabi) not therapeutically equivalent to J2270, up to 10 mg.
365. HCPCS Code J2274
HCPCS J2274 describes the injection of morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg.
366. HCPCS Code J2278
HCPCS J2278 describes the injection of ziconotide, 1 microgram.
367. HCPCS Code J2280
HCPCS J2280 describes the injection of moxifloxacin, 100 mg.
368. HCPCS Code J2281
HCPCS J2281 describes the injection of moxifloxacin (fresenius kabi) not therapeutically equivalent to J2280, 100 mg.
369. HCPCS Code J2300
HCPCS J2300 describes the injection of nalbuphine hydrochloride, per 10 mg.
370. HCPCS Code J2305
HCPCS J2305 describes the injection of nitroglycerin, 5 mg.
371. HCPCS Code J2310
HCPCS J2310 describes the injection of naloxone hydrochloride, per 1 mg.
372. HCPCS Code J2311
HCPCS J2311 describes the injection of naloxone hydrochloride (zimhi), 1 mg.
373. HCPCS Code J2315
HCPCS J2315 describes the injection of naltrexone, depot form, 1 mg.
374. HCPCS Code J2320
HCPCS J2320 describes the injection of nandrolone decanoate, up to 50 mg.
375. HCPCS Code J2323
HCPCS J2323 describes the injection of natalizumab, 1 mg.
376. HCPCS Code J2325
HCPCS J2325 describes the injection of nesiritide, 0.1 mg.
377. HCPCS Code J2326
HCPCS J2326 describes the injection of nusinersen, 0.1 mg.
378. HCPCS Code J2327
HCPCS J2327 describes the injection of risankizumab-rzaa, intravenous, 1 mg.
379. HCPCS Code J2329
HCPCS J2329 describes the injection of ublituximab-xiiy, 1 mg.
380. HCPCS Code J2350
HCPCS J2350 describes the injection of ocrelizumab, 1 mg.
381. HCPCS Code J2353
HCPCS J2353 describes the injection of octreotide, depot form for intramuscular injection, 1 mg.
382. HCPCS Code J2354
HCPCS J2354 describes the injection of octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg.
383. HCPCS Code J2355
HCPCS J2355 describes the injection of oprelvekin, 5 mg.
384. HCPCS Code J2356
HCPCS J2356 describes the injection of tezepelumab-ekko, 1 mg.
385. HCPCS Code J2357
HCPCS J2357 describes the injection of omalizumab, 5 mg.
386. HCPCS Code J2358
HCPCS J2358 describes the injection of olanzapine, long-acting, 1 mg.
387. HCPCS Code J2359
HCPCS J2359 describes the injection of olanzapine, 0.5 mg.
388. HCPCS Code J2360
HCPCS J2360 describes the injection of orphenadrine citrate, up to 60 mg.
389. HCPCS Code J2371
HCPCS J2371 describes the injection of phenylephrine hydrochloride, 20 micrograms.
390. HCPCS Code J2372
HCPCS J2372 describes the injection of phenylephrine hydrochloride (biorphen), 20 micrograms.
391. HCPCS Code J2401
HCPCS J2401 describes the injection of chloroprocaine hydrochloride, per 1 mg.
392. HCPCS Code J2402
HCPCS J2402 describes the injection of chloroprocaine hydrochloride (clorotekal), per 1 mg.
393. HCPCS Code J2403
HCPCS J2403 describes the chloroprocaine HCl ophthalmic, 3% gel, 1 mg.
394. HCPCS Code J2404
HCPCS J2404 describes the injection of nicardipine, 0.1 mg.
395. HCPCS Code J2405
HCPCS J2405 describes the injection of ondansetron hydrochloride, per 1 mg.
396. HCPCS Code J2406
HCPCS J2406 describes the injection of oritavancin (kimyrsa), 10 mg.
397. HCPCS Code J2407
HCPCS J2407 describes the injection of oritavancin (orbactiv), 10 mg.
398. HCPCS Code J2410
HCPCS J2410 describes the injection of oxymorphone HCl, up to 1 mg.
399. HCPCS Code J2425
HCPCS J2425 describes the injection of palifermin, 50 micrograms.
400. HCPCS Code J2426
HCPCS J2426 describes the injection of paliperidone palmitate extended release (invega sustenna), 1 mg.
401. HCPCS Code J2427
HCPCS J2427 describes the injection of paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg.
402. HCPCS Code J2430
HCPCS J2430 describes the injection of pamidronate disodium, per 30 mg.
403. HCPCS Code J2440
HCPCS J2440 describes the injection of papaverine HCl, up to 60 mg.
404. HCPCS Code J2460
HCPCS J2460 describes the injection of oxytetracycline HCl, up to 50 mg.
405. HCPCS Code J2469
HCPCS J2469 describes the injection of palonosetron HCl, 25 mcg.
406. HCPCS Code J2501
HCPCS J2501 describes the injection of paricalcitol, 1 mcg.
407. HCPCS Code J2502
HCPCS J2502 describes the injection of pasireotide long acting, 1 mg.
408. HCPCS Code J2503
HCPCS J2503 describes the injection of pegaptanib sodium, 0.3 mg.
409. HCPCS Code J2504
HCPCS J2504 describes the injection of pegademase bovine, 25 IU.
410. HCPCS Code J2506
HCPCS J2506 describes the injection of pegfilgrastim, excludes biosimilar, 0.5 mg.
411. HCPCS Code J2507
HCPCS J2507 describes the injection of pegloticase, 1 mg.
412. HCPCS Code J2508
HCPCS J2508 describes the injection of pegunigalsidase alfa-iwxj, 1 mg.
413. HCPCS Code J2510
HCPCS J2510 describes the injection of penicillin G procaine, aqueous, up to 600,000 units.
414. HCPCS Code J2513
HCPCS J2513 describes the injection of pentastarch, 10% solution, 100 ml.
415. HCPCS Code J2515
HCPCS J2515 describes the injection of pentobarbital sodium, per 50 mg.
416. HCPCS Code J2540
HCPCS J2540 describes the injection of penicillin G potassium, up to 600,000 units.
417. HCPCS Code J2543
HCPCS J2543 describes the injection of piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams).
418. HCPCS Code J2545
HCPCS J2545 describes the pentamidine isethionate, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per 300 mg.
419. HCPCS Code J2547
HCPCS J2547 describes the injection of peramivir, 1 mg.
420. HCPCS Code J2550
HCPCS J2550 describes the injection of promethazine HCl, up to 50 mg.
421. HCPCS Code J2560
HCPCS J2560 describes the injection of phenobarbital sodium, up to 120 mg.
422. HCPCS Code J2561
HCPCS J2561 describes the injection of phenobarbital sodium (sezaby), 1 mg.
423. HCPCS Code J2562
HCPCS J2562 describes the injection of plerixafor, 1 mg.
424. HCPCS Code J2590
HCPCS J2590 describes the injection of oxytocin, up to 10 units.
425. HCPCS Code J2597
HCPCS J2597 describes the injection of desmopressin acetate, per 1 mcg.
426. HCPCS Code J2598
HCPCS J2598 describes the injection of vasopressin, 1 unit.
427. HCPCS Code J2599
HCPCS J2599 describes the injection of vasopressin (american regent) not therapeutically equivalent to J2598, 1 unit.
428. HCPCS Code J2650
HCPCS J2650 describes the injection of prednisolone acetate, up to 1 ml.
429. HCPCS Code J2670
HCPCS J2670 describes the injection of tolazoline HCl, up to 25 mg.
430. HCPCS Code J2675
HCPCS J2675 describes the injection of progesterone, per 50 mg.
431. HCPCS Code J2679
HCPCS J2679 describes the injection of fluphenazine HCl, 1.25 mg.
432. HCPCS Code J2680
HCPCS J2680 describes the injection of fluphenazine decanoate, up to 25 mg.
433. HCPCS Code J2690
HCPCS J2690 describes the injection of procainamide HCl, up to 1 gm.
434. HCPCS Code J2700
HCPCS J2700 describes the injection of oxacillin sodium, up to 250 mg.
435. HCPCS Code J2704
HCPCS J2704 describes the injection of propofol, 10 mg.
436. HCPCS Code J2710
HCPCS J2710 describes the injection of neostigmine methylsulfate, up to 0.5 mg.
437. HCPCS Code J2720
HCPCS J2720 describes the injection of protamine sulfate, per 10 mg.
438. HCPCS Code J2724
HCPCS J2724 describes the injection of protein C concentrate, intravenous, human, 10 IU.
439. HCPCS Code J2725
HCPCS J2725 describes the injection of protirelin, per 250 mcg.
440. HCPCS Code J2730
HCPCS J2730 describes the injection of pralidoxime chloride, up to 1 gm.
441. HCPCS Code J2760
HCPCS J2760 describes the injection of phentolamine mesylate, up to 5 mg.
442. HCPCS Code J2765
HCPCS J2765 describes the injection of metoclopramide HCl, up to 10 mg.
443. HCPCS Code J2770
HCPCS J2770 describes the injection of quinupristin/dalfopristin, 500 mg (150/350).
444. HCPCS Code J2777
HCPCS J2777 describes the injection of faricimab-svoa, 0.1 mg.
445. HCPCS Code J2778
HCPCS J2778 describes the injection of ranibizumab, 0.1 mg.
446. HCPCS Code J2779
HCPCS J2779 describes the injection of ranibizumab, via intravitreal implant (susvimo), 0.1 mg.
447. HCPCS Code J2780
HCPCS J2780 describes the injection of ranitidine hydrochloride, 25 mg.
448. HCPCS Code J2781
HCPCS J2781 describes the injection of pegcetacoplan, intravitreal, 1 mg.
449. HCPCS Code J2783
HCPCS J2783 describes the injection of rasburicase, 0.5 mg.
450. HCPCS Code J2785
HCPCS J2785 describes the injection of regadenoson, 0.1 mg.
451. HCPCS Code J0285
HCPCS J0285 describes the injection of amphotericin B, 50 mg.
452. HCPCS Code J0287
HCPCS J0287 describes the injection of amphotericin B lipid complex, 10 mg.
453. HCPCS Code J0288
HCPCS J0288 describes the injection of amphotericin B cholesteryl sulfate complex, 10 mg.
454. HCPCS Code J0289
HCPCS J0289 describes the injection of amphotericin B liposome, 10 mg.
455. HCPCS Code J0290
HCPCS J0290 describes the injection of ampicillin sodium, 500 mg.
456. HCPCS Code J0291
HCPCS J0291 describes the injection of plazomicin, 5 mg.
457. HCPCS Code J0295
HCPCS J0295 describes the injection of ampicillin sodium/sulbactam sodium, per 1.5 gm.
458. HCPCS Code J0300
HCPCS J0300 describes the injection of amobarbital, up to 125 mg.
459. HCPCS Code J0330
HCPCS J0330 describes the injection of succinylcholine chloride, up to 20 mg.
460. HCPCS Code J0348
HCPCS J0348 describes the injection of anidulafungin, 1 mg.
461. HCPCS Code J2786
HCPCS J2786 describes the injection of reslizumab, 1 mg.
462. HCPCS Code J2787
HCPCS J2787 describes the riboflavin 5’-phosphate, ophthalmic solution, up to 3 ml.
463. HCPCS Code J2788
HCPCS J2788 describes the injection of Rho D immune globulin, human, minidose, 50 micrograms (250 IU).
464. HCPCS Code J2790
HCPCS J2790 describes the injection of Rho D immune globulin, human, full dose, 300 micrograms (1500 IU).
465. HCPCS Code J2791
HCPCS J2791 describes the injection of Rho D immune globulin (human), (Rhophylac), intramuscular or intravenous, 100 IU.
466. HCPCS Code J2792
HCPCS J2792 describes the injection of Rho D immune globulin, intravenous, human, solvent detergent, 100 IU.
467. HCPCS Code J2793
HCPCS J2793 describes the injection of rilonacept, 1 mg.
468. HCPCS Code J2794
HCPCS J2794 describes the injection of risperidone (risperdal consta), 0.5 mg.
469. HCPCS Code J2795
HCPCS J2795 describes the injection of ropivacaine hydrochloride, 1 mg.
470. HCPCS Code J2796
HCPCS J2796 describes the injection of romiplostim, 10 micrograms.
471. HCPCS Code J0349
HCPCS J0349 describes the injection of rezafungin, 1 mg.
472. HCPCS Code J0350
HCPCS J0350 describes the injection of anistreplase, per 30 units.
473. HCPCS Code J0360
HCPCS J0360 describes the injection of hydralazine HCl, up to 20 mg.
474. HCPCS Code J0364
HCPCS J0364 describes the injection of apomorphine hydrochloride, 1 mg.
475. HCPCS Code J0365
HCPCS J0365 describes the injection of aprotinin, 10,000 kiu.
476. HCPCS Code J0380
HCPCS J0380 describes the injection of metaraminol bitartrate, per 10 mg.
477. HCPCS Code J0390
HCPCS J0390 describes the injection of chloroquine hydrochloride, up to 250 mg.
478. HCPCS Code J0391
HCPCS J0391 describes the injection of artesunate, 1 mg.
479. HCPCS Code J0395
HCPCS J0395 describes the injection of arbutamine HCl, 1 mg.
480. HCPCS Code J0400
HCPCS J0400 describes the injection of aripiprazole, intramuscular, 0.25 mg.
481. HCPCS Code J0401
HCPCS J0401 describes the injection of aripiprazole, extended release, 1 mg.
482. HCPCS Code J0402
HCPCS J0402 describes the injection of aripiprazole (abilify asimtufii), 1 mg.
483. HCPCS Code J0456
HCPCS J0456 describes the injection of azithromycin, 500 mg.
484. HCPCS Code J0457
HCPCS J0457 describes the injection of aztreonam, 100 mg.
485. HCPCS Code J0461
HCPCS J0461 describes the injection of atropine sulfate, 0.01 mg.
486. HCPCS Code J0470
HCPCS J0470 describes the injection of dimercaprol, per 100 mg.
487. HCPCS Code J0475
HCPCS J0475 describes the injection of baclofen, 10 mg.
488. HCPCS Code J0476
HCPCS J0476 describes the injection of baclofen, 50 mcg for intrathecal trial.
489. HCPCS Code J0480
HCPCS J0480 describes the injection of basiliximab, 20 mg.
490. HCPCS Code J0485
HCPCS J0485 describes the injection of belatacept, 1 mg.
491. HCPCS Code J0490
HCPCS J0490 describes the injection of belimumab, 10 mg.
492. HCPCS Code J0491
HCPCS J0491 describes the injection of anifrolumab-fnia, 1 mg.
493. HCPCS Code J0500
HCPCS J0500 describes the injection of dicyclomine HCl, up to 20 mg.
494. HCPCS Code J0515
HCPCS J0515 describes the injection of benztropine mesylate, per 1 mg.
495. HCPCS Code J0517
HCPCS J0517 describes the injection of benralizumab, 1 mg.
496. HCPCS Code J0520
HCPCS J0520 describes the injection of bethanechol chloride, myotonachol or urecholine, up to 5 mg.
497. HCPCS Code J0558
HCPCS J0558 describes the injection of penicillin G benzathine and penicillin G procaine, 100,000 units.
498. HCPCS Code J0561
HCPCS J0561 describes the injection of penicillin G benzathine, 100,000 units.
499. HCPCS Code J0565
HCPCS J0565 describes the injection of bezlotoxumab, 10 mg.
500. HCPCS Code J0567
HCPCS J0567 describes the injection of cerliponase alfa, 1 mg.
501. HCPCS Code J0570
HCPCS J0570 describes the buprenorphine implant, 74.2 mg.
502. HCPCS Code J0571
HCPCS J0571 describes the oral buprenorphine, 1 mg.
503. HCPCS Code J0572
HCPCS J0572 describes the oral buprenorphine/naloxone, less than or equal to 3 mg buprenorphine.
504. HCPCS Code J0573
HCPCS J0573 describes the oral buprenorphine/naloxone, greater than 3 mg, but less than or equal to 6 mg buprenorphine.
505. HCPCS Code J0574
HCPCS J0574 describes the oral buprenorphine/naloxone, greater than 6 mg, but less than or equal to 10 mg buprenorphine.
506. HCPCS Code J0575
HCPCS J0575 describes the oral buprenorphine/naloxone, greater than 10 mg buprenorphine.
507. HCPCS Code J0576
HCPCS J0576 describes the injection of buprenorphine extended-release (brixadi), 1 mg.
508. HCPCS Code J0583
HCPCS J0583 describes the injection of bivalirudin, 1 mg.
509. HCPCS Code J0584
HCPCS J0584 describes the injection of burosumab-twza, 1 mg.
510. HCPCS Code J0585
HCPCS J0585 describes the injection of onabotulinumtoxinA, 1 unit.
Register free account to unlock the full article
Continue reading by logging in or creating your free Case2Code account. Gain full access instantly and explore our free code lookup tool.
No credit card required.